From Lab to ClinicLack of Prophylactic Effect of INCADRONATE (cas 138330-18-4) on Skeletal Lesions Associated with Implants of Prostate Cancer☆
-
Add time:08/22/2019 Source:sciencedirect.com
ObjectivesTo evaluate prophylactic effects of bisphosphonate (BP) on skeletal lesions induced by prostate cancer (CaP).
We also recommend Trading Suppliers and Manufacturers of INCADRONATE (cas 138330-18-4). Pls Click Website Link as below: cas 138330-18-4 suppliers
Prev:INCADRONATE (cas 138330-18-4) inhibits osteoporosis in ovariectomized rats
Next:Comparison of INCADRONATE (cas 138330-18-4) and alfacalcidol on increased bone turnover caused by ovariectomy in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Evaluation of long-term sequential changes in bone mass and strength following withdrawal of INCADRONATE (cas 138330-18-4) disodium (YM175) in ovariectomized rats08/25/2019
- Bisphosphonate INCADRONATE (cas 138330-18-4) prevents total gastrectomy-induced osteopenia in rats08/24/2019
- Comparison of INCADRONATE (cas 138330-18-4) and alfacalcidol on increased bone turnover caused by ovariectomy in rats08/23/2019
- INCADRONATE (cas 138330-18-4) inhibits osteoporosis in ovariectomized rats08/21/2019
- INCADRONATE (cas 138330-18-4) inhibits aminopeptidase N expression in prostatic PC-3 cells08/20/2019
- INCADRONATE (cas 138330-18-4) disodium inhibits advanced glycation end products-induced angiogenesis in vitro☆08/19/2019